Bekker, Pirow J <br/><br/>
A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women.  [electronic resource] 

 -  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research  Jul 2004 
 - 1059-66 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0884-0431 
<br/><br/><label>Standard No.: </label>10.1359/JBMR.040305  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Alkaline Phosphatase--blood<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Bone Resorption--drug therapy<br/>Calcium--blood<br/>Carrier Proteins--antagonists & inhibitors<br/>Cohort Studies<br/>Collagen--urine<br/>Collagen Type I<br/>Denosumab<br/>Female<br/>Humans<br/>Membrane Glycoproteins--antagonists & inhibitors<br/>Middle Aged<br/>Parathyroid Hormone--blood<br/>Peptides--urine<br/>RANK Ligand<br/>Receptor Activator of Nuclear Factor-kappa B